Furthermore, immunohistochemical analysis revealed that the downregulation of IGF2BP3 resulted in a significant decrease in Ki67 expression, a recognized indicator of tumor proliferation (Figure 3D). This evidence concerns the gene IGF2BP3 and neoplasm.